ALGN Stock Recent News

ROTKREUZ, Switzerland--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the launch in European Union countries and the United Kingdom of Align X-ray Insights, a new software-based (CADe*) computer aided detection solution that uses artifi.

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagnation.

Align Technology adds restorative capabilities to the iTero Lumina Solutions - the iTero Lumina intraoral scanner and the iTero Lumina Pro dental imaging system.

SAN JOSE, Calif. & TEMPE, Ariz. & PETACH TIKVA, Israel--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the addition of restorative capabilities to its next generation iTero Lumina™ intraoral scanner (without iTero Near Infra-Red Imaging (NIRI) tec.

Participating US doctors will have access to patient financing solutions for nearly every patient Participating US doctors will have access to patient financing solutions for nearly every patient

US stocks had a great 2024 but there still were names last year that failed to capitalise on the positive sentiment. A handful of them, however, are fairly positioned for a comeback this year, according to analysts at Jefferies.

Align Technology commercially launches its Invisalign Palatal Expander System in Turkey after approval from TMMDA.

ROTKREUZ, Switzerland--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align's Invisalign Palatal Expander System has been approved by the Turkish Medicines and Medical Device Agency (TMMDA) and is now commercially available in Turk.

Align Technology reports fourth-quarter 2024 revenue growth. This can be mostly attributed to the robust performance of the Imaging Systems & CAD/CAM Services business segment.